7Baggers

We provide you with 20 years of free, institutional-grade data for ACER stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ACER. Explore the full financial landscape of ACER stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
NameActionSharesAvg PriceAmountReported Date
Login to see more insider transactions
The information provided in this report about ACER stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Acer Therapeutics Inc
(NASDAQ:ACER) 

ACER stock logo

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients ...

Full Time Employees: 20
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends